文献速递消化道肿瘤与早癌消化内镜

一级亲属结直肠癌家族史与异时性结直肠腺瘤的关系

Family history of colorectal cancer in first-degree relatives and metachronous colorectal adenoma.
PubMed 文献 · Am J Gastroenterol · 2018-02-20

该研究汇总7项前瞻性研究、7697例既往已切除结直肠腺瘤患者的数据,分析一级亲属结直肠癌家族史与异时性结直肠腺瘤风险的关系。结果显示,任何一级亲属阳性家族史与异时性结直肠腺瘤风险轻度升高相关(OR=1.14;95%CI=1.01-1.29),母亲或兄弟姐妹受累时风险更高,且风险随受累一级亲属数量增加而升高;兄弟姐妹诊断年龄越轻,风险越高(p-trend=0.008)。

要点

  • 任何一级亲属结直肠癌家族史与异时性结直肠腺瘤风险轻度升高相关(OR=1.14;95%CI=1.01-1.29)。
  • 母亲(OR=1.27;95%CI=1.05-1.53)或兄弟姐妹(OR=1.34;95%CI=1.11-1.62)受累时风险升高,父亲受累未见关联。
  • 兄弟姐妹诊断年龄<54岁时异时性结直肠腺瘤风险升高(OR=1.66;95%CI=1.08-2.56),p-trend=0.008。

核心结论

  • 结直肠癌家族史与异时性结直肠腺瘤风险轻度升高相关。
  • 未来研究应探索一级亲属结直肠癌家族史(尤其是年轻发病)是否应在监测性结肠镜风险分层中发挥作用。

研究设计与样本

  • 汇总7项前瞻性研究、7697例既往已切除结直肠腺瘤患者的数据,分析一级亲属结直肠癌家族史与异时性腺瘤风险的关系。

主要发现

  • 与无结直肠癌家族史相比,任何一级亲属阳性家族史与异时性结直肠腺瘤风险升高显著相关(OR=1.14;95%CI=1.01-1.29)。
  • 与无相应家族史者相比,母亲受累者(OR=1.27;95%CI=1.05-1.53)或兄弟姐妹受累者(OR=1.34;95%CI=1.11-1.62)异时性结直肠腺瘤风险升高,父亲受累者未见关联。
  • 异时性结直肠腺瘤风险随受累一级亲属数量增加而升高:1个亲属OR=1.07(95%CI=0.93-1.23),2个及以上亲属OR=1.39(95%CI=1.02-1.91)。
  • 兄弟姐妹诊断年龄越轻,异时性结直肠腺瘤风险越高:<54岁OR=1.66(95%CI=1.08-2.56),55-64岁OR=1.34(95%CI=0.89-2.03),>65岁OR=1.10(95%CI=0.70-1.72),p-trend=0.008。
  • 受样本量限制,进展期异时性结直肠腺瘤的结果与任何异时性结直肠腺瘤相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 进展期异时性结直肠腺瘤的分析受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Little is known about the relationship between having a first-degree relative (FDR) with colorectal cancer (CRC) and risk for metachronous colorectal adenoma (CRA) following polypectomy. METHODS: We pooled data from seven prospective studies of 7697 patients with previously resected CRAs to quantify the relationship between having a FDR with CRC and risk for metachronous adenoma. RESULTS: Compared with having no family history of CRC, a positive family history in any FDR was significantly associated with increased odds of developing any metachronous CRA (OR = 1.14; 95% CI = 1.01-1.29). Higher odds of CRA were observed among individuals with an affected mother (OR = 1.27; 95% CI = 1.05-1.53) or sibling (OR = 1.34; 95% CI = 1.11-1.62) as compared with those without, whereas no association was shown for individuals with an affected father. Odds of having a metachronous CRA increased with number of affected FDRs, with ORs (95% CIs) of 1.07 (0.93-1.23) for one relative and 1.39 (1.02-1.91) for two or more. Younger age of diagnosis of a sibling was associated with higher odds of metachronous CRA, with ORs (95% CIs) of 1.66 (1.08-2.56) for diagnosis at <54 years; 1.34 (0.89-2.03) for 55-64 years; and 1.10 (0.70-1.72) for >65 years (p-trend = 0.008). Although limited by sample size, results for advanced metachronous CRA were similar to those for any metachronous CRA. CONCLUSIONS: A family history of CRC is related to a modestly increased odds of metachronous CRA. Future research should explore whether having a FDR with CRC, particularly at a young age, should have a role in risk stratification for surveillance colonoscopy.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Jacobs ET, Gupta S, Baron JA, et al. Family history of colorectal cancer in first-degree relatives and metachronous colorectal adenoma. Am J Gastroenterol. 2018. PMID: 29463834. doi:10.1038/s41395-018-0007-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。